Pharma Equity Group

About Pharma Equity Group

Pharma Equity Group is a pharmaceutical investment group focused on supporting its subsidiary, Reponex Pharmaceuticals, in developing new effective medicines for the local treatment of serious, acute, and chronic inflammatory diseases. Their mission is to address significant unmet medical needs that impact patients and society, for which no optimal treatments currently exist.

Products & Services

Reponex Pharmaceuticals Drug Development:Focused on novel drug formulations and cutting-edge delivery systems for unmet medical needs, particularly in stage 2 clinical development. Their strategy emphasizes local drug administration to maximize therapeutic benefits and minimize risks.

Specialties

Local Drug Administration Inflammatory Disease Treatment Biopharmaceutical Asset Development Clinical Development (Stage 2) Novel Drug Formulations Cutting-edge Delivery Systems

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Loan T: - FT: Convertible Loan	A: 846732 MR: - FA: DKK 5,842,500 FAN: 846732	D: 2025-07-01 FD: 2025-07-01	-

Convertible Loan Latest

2025-07-01

$847K

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lars Gundorph

Board Member

LinkedIn (Pro only)

T

Troels Peter Troelsen

Board Member

LinkedIn (Pro only)

C

Christian Vinding Thomsen

Member

P

Peter Vilmann

Chairman of the Business, Research and Development Committee

O

Omar S. Qandeel

Board Member

C

Charlotte Pahl

Director at Sobi AB, Global Medical Affairs, Hematology

View 14 more team members with Pro

Unlock Full Team Directory

Recent News